Adicet Bio
ACET
ACET
66 hedge funds and large institutions have $218M invested in Adicet Bio in 2021 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 18 increasing their positions, 15 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
18% less capital invested
Capital invested by funds: $266M → $218M (-$48.2M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $2K
Holders
66
Holding in Top 10
1
Calls
–
Puts
$2K
Top Buyers
| 1 | +$7.67M | |
| 2 | +$2.6M | |
| 3 | +$2.48M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.05M |
| 5 |
6CM
683 Capital Management
New York
|
+$2.01M |
Top Sellers
| 1 | -$8.4M | |
| 2 | -$1.97M | |
| 3 | -$1.26M | |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
-$938K |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$878K |